Literature DB >> 33682260

Mechanical circulatory support in acute myocardial infarction and cardiogenic shock: Challenges and importance of randomized control trials.

Mir B Basir1, Duane S Pinto2, Boback Ziaeian3, Akshay Khandelwal1, Jennifer Cowger1, William Suh3, Andrew Althouse4.   

Abstract

BACKGROUND: Acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) is associated with significant morbidity and mortality.
METHODS: We provide an overview of previously conducted studies on the use of mechanical circulatory support (MCS) devices in the treatment of AMI-CS and difficulties which may be encountered in conducting such trials in the United States.
RESULTS: Well powered randomized control trials are difficult to conduct in a critically ill patient population due to physician preferences, perceived lack of equipoise and challenges obtaining informed consent.
CONCLUSIONS: With growth in utilization of MCS devices in patients with AMI-CS, efforts to perform well-powered, randomized control trials must be undertaken.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  ECMO/IABP/Tandem/Impella; acute myocardial infarction/STEMI; cardiogenic shock; clinical trials; mechanical circulatory support

Mesh:

Year:  2021        PMID: 33682260      PMCID: PMC8421448          DOI: 10.1002/ccd.29593

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  36 in total

1.  Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock.

Authors:  Mir B Basir; Theodore L Schreiber; Cindy L Grines; Simon R Dixon; Jeffrey W Moses; Brijeshwar S Maini; Akshay K Khandelwal; E Magnus Ohman; William W O'Neill
Journal:  Am J Cardiol       Date:  2016-12-18       Impact factor: 2.778

2.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao; Jeffrey L Anderson; Alice K Jacobs; Jonathan L Halperin; Nancy M Albert; Ralph G Brindis; Mark A Creager; David DeMets; Robert A Guyton; Judith S Hochman; Richard J Kovacs; Frederick G Kushner; E Magnus Ohman; William G Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2012-12-17       Impact factor: 29.690

3.  Standardized Team-Based Care for Cardiogenic Shock.

Authors:  Behnam N Tehrani; Alexander G Truesdell; Matthew W Sherwood; Shashank Desai; Henry A Tran; Kelly C Epps; Ramesh Singh; Mitchell Psotka; Palak Shah; Lauren B Cooper; Carolyn Rosner; Anika Raja; Scott D Barnett; Patricia Saulino; Christopher R deFilippi; Paul A Gurbel; Charles E Murphy; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2019-04-09       Impact factor: 24.094

4.  Extra corporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO-CS): rationale and design of the multicenter randomized trial.

Authors:  Petr Ostadal; Richard Rokyta; Andreas Kruger; Dagmar Vondrakova; Marek Janotka; Ondrej Smíd; Jana Smalcova; Milan Hromadka; Ales Linhart; Jan Bělohlávek
Journal:  Eur J Heart Fail       Date:  2017-05       Impact factor: 15.534

5.  National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis.

Authors:  Robert Stretch; Christopher M Sauer; David D Yuh; Pramod Bonde
Journal:  J Am Coll Cardiol       Date:  2014-10-07       Impact factor: 24.094

6.  The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support.

Authors:  Amit P Amin; John A Spertus; Jeptha P Curtis; Nihar Desai; Frederick A Masoudi; Richard G Bach; Christian McNeely; Firas Al-Badarin; John A House; Hemant Kulkarni; Sunil V Rao
Journal:  Circulation       Date:  2019-11-17       Impact factor: 29.690

7.  Intraaortic balloon support for myocardial infarction with cardiogenic shock.

Authors:  Holger Thiele; Uwe Zeymer; Franz-Josef Neumann; Miroslaw Ferenc; Hans-Georg Olbrich; Jörg Hausleiter; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Georg Fuernau; Steffen Desch; Ingo Eitel; Rainer Hambrecht; Jörg Fuhrmann; Michael Böhm; Henning Ebelt; Steffen Schneider; Gerhard Schuler; Karl Werdan
Journal:  N Engl J Med       Date:  2012-08-26       Impact factor: 91.245

8.  Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: A report from NCDR.

Authors:  Monique L Anderson; Eric D Peterson; S Andrew Peng; Tracy Y Wang; E Magnus Ohman; Deepak L Bhatt; Jorge F Saucedo; Matthew T Roe
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-11-12

9.  Outcomes of venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock: systematic review and meta-analysis.

Authors:  Ashley R Wilson-Smith; Yulia Bogdanova; Stephanie Roydhouse; Kevin Phan; David H Tian; Tristan D Yan; Antonio Loforte
Journal:  Ann Cardiothorac Surg       Date:  2019-01

10.  Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.

Authors:  Karl Heinrich Scholz; Sebastian K G Maier; Lars S Maier; Björn Lengenfelder; Claudius Jacobshagen; Jens Jung; Claus Fleischmann; Gerald S Werner; Hans G Olbrich; Rainer Ott; Harald Mudra; Karlheinz Seidl; P Christian Schulze; Christian Weiss; Josef Haimerl; Tim Friede; Thomas Meyer
Journal:  Eur Heart J       Date:  2018-04-01       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.